Trump Meets With Two FDA Commissioner Candidates; Third Still In Play

O'Neill and Srinivasan head to Trump Tower, but Gottlieb has not been eliminated.

Trump Tower

President-elect Donald Trump interviewed what appear to be two unconventional candidates for FDA commissioner, but at least one other potential selection remains among those that could receive the nomination.

The transition team indicated that Trump met with Jim O'Neill, managing director of Mithril Capital Management, and Balaji Srinivasan, partner...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

US Tariff Exemption For Indonesian Materials Not Produced Domestically A Boon For Fragrance – FCA

 

The Fragrance Creators Association President & CEO Farah Ahmed commends the Trump Administration for exempting from tariffs Indonesian goods not naturally available or produced in the US, which recognizes the “essential” role of fragrance and essential oils.